IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase
| Main Authors: | Jackaman, Connie, Lansley, S., Allan, J., Robinson, B., Nelson, Delia |
|---|---|
| Format: | Journal Article |
| Published: |
Oxford University Press
2012
|
| Online Access: | http://intimm.oxfordjournals.org/content/24/6/369.full.pdf+html http://hdl.handle.net/20.500.11937/49276 |
Similar Items
CD40-activated B cells contribute to mesothelioma tumor regression
by: Jackaman, Connie, et al.
Published: (2011)
by: Jackaman, Connie, et al.
Published: (2011)
IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice
by: Jackaman, Connie, et al.
Published: (2014)
by: Jackaman, Connie, et al.
Published: (2014)
Murine mesothelioma induces locally-proliferating IL-10+TNF-a+CD206-CX3CR1+ M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy
by: Jackaman, Connie, et al.
Published: (2016)
by: Jackaman, Connie, et al.
Published: (2016)
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ - independent resolution of treated-turmors and CD4+ -dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)
by: Jackaman, Connie, et al.
Published: (2012)
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)
by: Jackaman, Connie, et al.
Published: (2012)
Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function
by: Gardner, J., et al.
Published: (2015)
by: Gardner, J., et al.
Published: (2015)
Rapid copper acquisition by developing murine mesothelioma: Decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration
by: Crowe, Andrew, et al.
Published: (2013)
by: Crowe, Andrew, et al.
Published: (2013)
The Regulatory Status Adopted by Lymph Node Dendritic Cells and T Cells During Healthy Aging Is Maintained During Cancer and May Contribute to Reduced Responses to Immunotherapy
by: Gardner, J., et al.
Published: (2018)
by: Gardner, J., et al.
Published: (2018)
Lipid-laden partially-activated plasmacytoid and CD4-CD8a+ dendritic cells accumulate in tissues in elderly mice
by: Gardner, Joanne, et al.
Published: (2014)
by: Gardner, Joanne, et al.
Published: (2014)
Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo
by: Jackaman, Connie, et al.
Published: (2012)
by: Jackaman, Connie, et al.
Published: (2012)
Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?
by: Jackaman, Connie, et al.
Published: (2013)
by: Jackaman, Connie, et al.
Published: (2013)
Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation
by: Gardner, J., et al.
Published: (2018)
by: Gardner, J., et al.
Published: (2018)
The use of agonistic anti-CD40 therapy in treatments for cancer
by: Khong, A., et al.
Published: (2012)
by: Khong, A., et al.
Published: (2012)
Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules
by: Gardner, J., et al.
Published: (2017)
by: Gardner, J., et al.
Published: (2017)
MESOTHELIOMA IN AUSTRALIA-RESULTS FROM THE AUSTRALIAN MESOTHELIOMA REGISTRY
by: Sim, M., et al.
Published: (2016)
by: Sim, M., et al.
Published: (2016)
Human mesothelioma induces defects in dendritic cell numbers and antigen processing function which predict survival outcomes
by: Cornwall, S., et al.
Published: (2015)
by: Cornwall, S., et al.
Published: (2015)
Current techniques in reprogramming cell potency
by: Romli, Firdaus, et al.
Published: (2013)
by: Romli, Firdaus, et al.
Published: (2013)
Combining chemotherapy with immunotherapy to treat mesothelioma: an investigation into the role of CD4+ T cells in a murine model
by: Steer, Henry John
Published: (2013)
by: Steer, Henry John
Published: (2013)
Palliative care in mesothelioma
by: Brims, Fraser
Published: (2018)
by: Brims, Fraser
Published: (2018)
Sarcostemma viminale activates macrophages to a pro-inflammatory phenotype
by: Brestovac, Brian, et al.
Published: (2014)
by: Brestovac, Brian, et al.
Published: (2014)
The Potency of Interdisciplinary Collaboration to Empower Constructive Dissenters
by: Symons, Christine, et al.
Published: (2012)
by: Symons, Christine, et al.
Published: (2012)
Cannabis potency and contamination: a review of the literature.
by: McLaren, J., et al.
Published: (2008)
by: McLaren, J., et al.
Published: (2008)
Modulation of IL-10 production by CD3/CD55 induced Type 1 regulatory (Tr1) T-cells
by: Musarrat, Tajkia
Published: (2019)
by: Musarrat, Tajkia
Published: (2019)
CD8+ cytotoxic T cell responses to dominant tumor-associated antigens are profoundly weakened by aging yet subdominant responses retain functionality and expand in response to chemotherapy
by: Jackaman, Connie, et al.
Published: (2019)
by: Jackaman, Connie, et al.
Published: (2019)
Henoch-Schonlein purpura in mesothelioma
by: Joshi, S., et al.
Published: (2014)
by: Joshi, S., et al.
Published: (2014)
Wnt Signalling in Malignant Mesothelioma
by: Richards, Alexander S.K.
Published: (2016)
by: Richards, Alexander S.K.
Published: (2016)
Mesothelioma in australia: A review
by: Musk, A., et al.
Published: (2017)
by: Musk, A., et al.
Published: (2017)
Predicting survival in malignant mesothelioma
by: Musk, A., et al.
Published: (2011)
by: Musk, A., et al.
Published: (2011)
Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans
by: Robinson, C., et al.
Published: (2014)
by: Robinson, C., et al.
Published: (2014)
Potency and species specificity of aryl hydrocarbon receptor ligands
by: Wall, Richard John
Published: (2012)
by: Wall, Richard John
Published: (2012)
Stromal fibroblasts support dendritic cells to maintain IL-23/Th17 responses after exposure to ionizing radiation
by: Malecka, Anna, et al.
Published: (2016)
by: Malecka, Anna, et al.
Published: (2016)
Install
by: Lyons, Shannon
Published: (2011)
by: Lyons, Shannon
Published: (2011)
Genetic Polymorphism of KIR2DL4 (CD158d), a Putative NK Cell Receptor for HLA-G, Does Not Influence Susceptibility to Asthma
by: Le Page, M., et al.
Published: (2013)
by: Le Page, M., et al.
Published: (2013)
Increased proportion of the CD56bright NK cell subset in patients chronically infected with Hepatitis C Virus (HCV) receiving interferon-a and ribavirin therapy
by: Lee, S., et al.
Published: (2010)
by: Lee, S., et al.
Published: (2010)
Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice
by: Jackaman, Connie, et al.
Published: (2013)
by: Jackaman, Connie, et al.
Published: (2013)
Epidemiology of Malignant Pleural Mesothelioma in Australia
by: De Klerk, N., et al.
Published: (2016)
by: De Klerk, N., et al.
Published: (2016)
Prognostic factors for malignant pleural mesothelioma
by: Brims, Fraser, et al.
Published: (2013)
by: Brims, Fraser, et al.
Published: (2013)
IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose–dependently activated via IL-36β and induces CD4+ lymphocyte proliferation
by: Penha, Rafael, et al.
Published: (2016)
by: Penha, Rafael, et al.
Published: (2016)
A genome-wide association study for malignant mesothelioma risk
by: Cadby, G., et al.
Published: (2013)
by: Cadby, G., et al.
Published: (2013)
Potency of selected berries, grapes and citrus fruit as neuroprotective agents
by: Tan, Shih Jen, et al.
Published: (2020)
by: Tan, Shih Jen, et al.
Published: (2020)
Similar Items
-
CD40-activated B cells contribute to mesothelioma tumor regression
by: Jackaman, Connie, et al.
Published: (2011) -
IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice
by: Jackaman, Connie, et al.
Published: (2014) -
Murine mesothelioma induces locally-proliferating IL-10+TNF-a+CD206-CX3CR1+ M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy
by: Jackaman, Connie, et al.
Published: (2016) -
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ - independent resolution of treated-turmors and CD4+ -dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012) -
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)